Enhancement of cetuximab-induced antibody-dependent cellular cytotoxicity (ADCC) with lenalidomide in advanced solid tumors: A phase 1 trial.
Erin Marie Bertino
No relevant relationships to disclose
Elizabeth L McMichael
No relevant relationships to disclose
Miguel Angel Villalona-Calero
No relevant relationships to disclose
Michael R. Grever
No relevant relationships to disclose
William Edgar Carson
No relevant relationships to disclose
Gregory Alan Otterson
Research Funding - NCCN - Abraxis now Celgene